http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114875156-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d0451e593692e9996ee1672449fb2fe |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2022-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1ca14bb325159c32c32c74e242c6e76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d943dd0037d1de990858f1347031a8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7a58655eb04806b0cbe444e60f7ce61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ddc108c0b4e9c796ceecc6ea7dcc0a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db9bbc2df341b3912cea8b230eb005ff |
| publicationDate | 2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114875156-A |
| titleOfInvention | Application of MOGAT2 in the preparation of hepatocellular carcinoma diagnosis and prognosis judgment products |
| abstract | The invention discloses the application of MOGAT2 in the preparation of hepatocellular carcinoma diagnosis and prognosis judgment products, and belongs to the field of molecular markers. Also disclosed is the application of the reagent for detecting the expression level of MOGAT2 in the preparation of a kit for predicting the prognosis of a patient with hepatocellular carcinoma. The present invention verifies that MOGAT2 is lowly expressed in hepatocellular carcinoma tissue and highly expressed in adjacent normal liver tissue through experiments, and the diagnosis and/or prognosis judgment of hepatocellular carcinoma can be performed by detecting the expression level of the molecular marker MOGAT2, which can supplement and improve the diagnosis of liver cancer. and prognostic deficiencies of current screening strategies. |
| priorityDate | 2022-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 332.